Search research articles
Contact Us
Filters
Showing results (251-260 of 361) with videos related to
Page
of 37
Sort By:
Gut
|
January 14, 2005
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery
L Ciccolallo, R Capocaccia, M P Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2003
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary
M Sant, T Aareleid, F Berrino, et al.
Molecular Cancer Therapeutics
|
May 5, 2017
Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors
Lloyd T Lam, Xiaoyu Lin, Emily J Faivre, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 7, 2006
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)
N Bossard, M Velten, L Remontet, et al.
Revue D'Epidemiologie Et De Sante Publique
|
April 10, 2003
Cancer incidence and mortality in France over the period 1978-2000
L Remontet, J Estève, A-M Bouvier, et al.
Cancer Research
|
April 19, 2017
Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
Mai H Bui, Xiaoyu Lin, Daniel H Albert, et al.
Revue D'Epidemiologie Et De Sante Publique
|
June 13, 2008
Cancer incidence and mortality in France over the period 1980-2005
A Belot, P Grosclaude, N Bossard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2003
European health systems and cancer care
A Micheli, J W Coebergh, E Mugno, et al.
Molecular Cancer Therapeutics
|
July 13, 2021
Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia
Lu Zhang, Tianyu Cai, Xiaoyu Lin, et al.
Journal of Medicinal Chemistry
|
September 27, 2017
Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor
Keith F McDaniel, Le Wang, Todd Soltwedel, et al.
Page
of 37
Search research articles
Search
Showing results (251-260 of 361) with videos related to
Sort By:
Page
of 37
Gut
|
January 14, 2005
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery
L Ciccolallo, R Capocaccia, M P Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2003
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary
M Sant, T Aareleid, F Berrino, et al.
Molecular Cancer Therapeutics
|
May 5, 2017
Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors
Lloyd T Lam, Xiaoyu Lin, Emily J Faivre, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 7, 2006
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM)
N Bossard, M Velten, L Remontet, et al.
Revue D'Epidemiologie Et De Sante Publique
|
April 10, 2003
Cancer incidence and mortality in France over the period 1978-2000
L Remontet, J Estève, A-M Bouvier, et al.
Cancer Research
|
April 19, 2017
Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
Mai H Bui, Xiaoyu Lin, Daniel H Albert, et al.
Revue D'Epidemiologie Et De Sante Publique
|
June 13, 2008
Cancer incidence and mortality in France over the period 1980-2005
A Belot, P Grosclaude, N Bossard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2003
European health systems and cancer care
A Micheli, J W Coebergh, E Mugno, et al.
Molecular Cancer Therapeutics
|
July 13, 2021
Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia
Lu Zhang, Tianyu Cai, Xiaoyu Lin, et al.
Journal of Medicinal Chemistry
|
September 27, 2017
Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor
Keith F McDaniel, Le Wang, Todd Soltwedel, et al.
Page
of 37